A detailed history of Tiaa, Fsb transactions in Moderna, Inc. stock. As of the latest transaction made, Tiaa, Fsb holds 5,015 shares of MRNA stock, worth $201,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,015
Previous 4,898 2.39%
Holding current value
$201,954
Previous $752,000 19.02%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$118.5 - $160.53 $13,864 - $18,782
117 Added 2.39%
5,015 $609,000
Q1 2023

Apr 19, 2023

SELL
$135.66 - $197.02 $57,384 - $83,339
-423 Reduced 7.95%
4,898 $752,000
Q4 2022

Jan 12, 2023

BUY
$118.38 - $210.04 $225,158 - $399,496
1,902 Added 55.63%
5,321 $956,000
Q3 2022

Oct 11, 2022

SELL
$118.07 - $194.18 $58,208 - $95,730
-493 Reduced 12.6%
3,419 $404,000
Q2 2022

Aug 09, 2022

BUY
$117.13 - $176.59 $458,212 - $690,820
3,912 New
3,912 $559,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Tiaa, Fsb Portfolio

Follow Tiaa, Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.